Decoy Therapeutics is trading 5.8% down at $4.75 in after-hours trading, extending a sharp multi-day slide from mid-July highs near $6.
- There are no fresh company-specific filings, press releases, earnings, or major analyst actions today linked to the move.
- Broader indices are trading roughly flat to slightly positive, suggesting the decline is stock-specific rather than market-driven.